NCT02490371

Brief Summary

Stroke is the leading cause of function disability or impairment. Non-promising functional return from upper limb rehabilitation has been reported. With the technology advances, transcranial magnetic stimulation (TMS), which is a form of non-invasive direct brain stimulation, may act as an attenuator in regulating or modulating the cortical excitability in order to facilitate cortical re-organization and enhance behavioral performance. Various therapeutic exercise protocols have been investigated regarding their efficacy in promoting motor recovery of the affected upper limb for patients after stroke and the preliminary results were supportive. However, limited numbers of randomized control clinical trials have been published in investigating the "priming" or "additive" value of low frequency repetitive TMS (rTMS) with combination of structural motor training programs. Thus the objective of this study is: to determine the effectiveness of the combination of low frequency rTMS on contra-lesional M1 and a structured upper limb motor training program on restoring upper limb function among patients with stroke in sub-acute stage. It is hypothesized that the rTMS, when combined with a structured motor training program, confers additional therapeutic effects on upper limb motor function in subacute stroke patients, when compared with the motor training program alone. The objectives of this study is to determine the effectiveness of the combination of low frequent rTMS on contra-lesional M1 and a structured upper limb motor training program in restoring upper limb function among patients with subacute stroke.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
24

participants targeted

Target at below P25 for not_applicable stroke

Timeline
Completed

Started Dec 2015

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 31, 2015

Completed
1 month until next milestone

First Posted

Study publicly available on registry

July 3, 2015

Completed
5 months until next milestone

Study Start

First participant enrolled

December 1, 2015

Completed
1.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2017

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2017

Completed
2.4 years until next milestone

Results Posted

Study results publicly available

September 26, 2019

Completed
Last Updated

September 26, 2019

Status Verified

June 1, 2019

Enrollment Period

1.4 years

First QC Date

May 31, 2015

Results QC Date

April 17, 2018

Last Update Submit

September 25, 2019

Conditions

Outcome Measures

Primary Outcomes (1)

  • Change of Cortical Excitability From Baseline to at 4th Weeksand 12th Weeks Training in Motor Evoked Potential at 120% Resting MotorThreshold at Affected Hand

    Electromyographic (EMG) activity in first doral interossei measured at 120% resting motor threshold. The motor evoked potential amplitude will be measured peak to peak in millivolt(mV). Higher value mean better control

    Baseline and at 4th weeks and at 12th weeks

Secondary Outcomes (5)

  • Change of Upper Limb Impairment From Baseline to at 4th Weeks & 12 th Weeks Training in Fugl-Meyer Assessment (FM) Scale

    Baseline and at 4th weeks and at 12th weeks

  • Change of Grip Strength From Baseline to at 4th Weeks and at 12th Weeks Training in Force (Kilogram )

    Baseline and at 4th weeks and at 12th weeks

  • Change of Upper Limb Function From Baseline to at 4th Weeks Training in Action Research Arm Test (ARAT) Scale

    Baseline and at 4th weeks and at 12th weeks

  • Change of Reaction Time From Baseline to at 4th Weeks and at 12th Weeks Training in Time Measurement (Seconds)

    Baseline and at 4th weeks and at 12th weeks

  • Change of Health Status Measurement From Baseline to at 4th Weeks and at 12th Weeks in Stroke Impact Scale

    Baseline and at 4th & 12 th weeks

Study Arms (2)

(1) rTMS- PT Ex Group

EXPERIMENTAL

1 Hz low frequency rTMS over contra-lesional M1 region for 1200 pulse (20 minutes) at 90% resting motor threshold (rMT) will conduct for 10 consecutive sessions (5 days per week for 2 weeks) and immediately followed by 30- minutes structured physiotherapy upper limb training. After the 10 sessions of brain stimulation, the 30-minute structured physiotherapy upper limb training program will continue for another 12 weeks (2 sessions per week)

Device: Low frequency rTMSBehavioral: structured physiotherapy upper limb training

(2) Placebo- PT Ex Group

PLACEBO COMPARATOR

placebo stimulation over contra-lesional M1 region will be conducted for 10 consecutive sessions (5 sessions per week for 2 weeks) of and immediately followed by 30- minutes of structured physiotherapy upper limb training. Then, the structured physiotherapy upper limb training will continue for another 12 weeks (2 sessions per week).

Device: Low frequency rTMSBehavioral: structured physiotherapy upper limb training

Interventions

1 Hz low frequency rTMS over contra-lesional M1 region for 1200 pulse at 90% resting motor threshold for 10 sessions.Patients in the rTMS-ex group will receive the experimental rTMS A Magstim Rapid Stimulator (Magstim Company, Whitland, UK) equipped with an air-cooled figure-of-eight coil (each loop 70 mm in diameter) and neuro-navigation system will be used to deliver the intervention.

(1) rTMS- PT Ex Group(2) Placebo- PT Ex Group

Structural Physiotherapy upper limb training for 30-minutes

(1) rTMS- PT Ex Group(2) Placebo- PT Ex Group

Eligibility Criteria

AgeUp to 85 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • First-ever stroke
  • Age \>60
  • muscle strength \> grade 2 and \< grade 5 based on manual muscle testing of hand / fingers of the affected upper limb
  • \> 1 month and \< 6 months after the onset of stroke

You may not qualify if:

  • Substantial cognitive impairment with Mini Mental State Test \>24
  • Diagnosis of mental illness
  • Pathological conditions referred to as contra-indications for rTMS in guideline suggested by Wassermann (eg. Cardiac pacemaker, intracranial implants, implanted medication pumps, epilepsy)
  • Unstable cardio-pulmonary conditions -

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Queen Elizabeth Hospital

Hong Kong, China

Location

MeSH Terms

Conditions

Stroke

Condition Hierarchy (Ancestors)

Cerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular Diseases

Results Point of Contact

Title
Dr. Helen LUK
Organization
QEHHongKong

Study Officials

  • Ka yan LUK

    Senior Physiotherapist

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Senior Physiotherapist

Study Record Dates

First Submitted

May 31, 2015

First Posted

July 3, 2015

Study Start

December 1, 2015

Primary Completion

May 1, 2017

Study Completion

May 1, 2017

Last Updated

September 26, 2019

Results First Posted

September 26, 2019

Record last verified: 2019-06

Data Sharing

IPD Sharing
Will not share

Locations